AddLife ABOMXSTO: ALIF_B

ALIF_B: Stable growth, margin improvement, and strategic acquisition position AddLife for a strong Q4

· Issued by AddLife AB

Sales grew 1% with stable margins and improved cash flow, driven by Medtech margin gains and cost reductions. Acquisition of BonsaiLab and Camanio closure support long-term strategy and profitability.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

AddLife AB on 6ix

In the deck

Earlier from AddLife

Later from AddLife

All AddLife news releases